Publications

1. Berton C, Klingler S, Prytuliak S, Holland J. P. New tactics in the design of theranostic radiotracers. Npj Imaging, 2024, 2(1), 23. DOI:10.1038/s44303-024-00027-1

2. Moreno-Alcántar G, Drexler M, Casini A. Assembling a new generation of radiopharmaceuticals with supramolecular theranostics. Nature Reviews Chemistry, 2024, 8, 893-914. DOI:10.1038/s41570-024-00657-4 

3. Greenwood H. E, Barber A. R, Edwards R. S, Tyrrell W. E, George M. E, dos Santos S. N, Baark F, Tanc M, Khalil E, Falzone A, Ward N. P, DeBlasi J. M, Torrente L, Soni P. N, Pearce D. R, Firth G, Smith L. M, Vilhelmsson Timmermand O, Huebner, A, Swanton C, Hynds R. E, DeNicola G. M, Witney, T. H. Imaging NRF2 activation in non-small cell lung cancer with positron emission tomography. Nature Communications, 2024, 15(1), 10484. DOI:10.1038/s41467-024-54852-4

4. Berton C, Holland J. P. Gold metallacages: Light-induced chemistry for protein functionalisation. Chem. Commun. 2025, 61, 5234. DOI:10.1039/d4cc06529h

5. Thomas, S.R,  Willnhammer N, Casini, A, Moreno-Alcántar, G. Gold metallacages: Design principles and applications. Chem, 2025, 11, 102502. DOI:10.1016/j.chempr.2025.102502

6. Spreckelmeyer S, Thomas S.R, Schuderer F, Pinto C.GI, de Andrade Querino A-L., Böhm F.A, Park M, Geppert C, Gorges C, Mendes F, Casini A. N-Heterocyclic Carbenes as Ligands to ¹⁹⁸Au(I)-Radiolabeled Compounds: A New Platform for Radiopharmaceutical Design J.Med.Chem. 2025, 68, 16, 17516–17526. DOI:10.1021/acs.jmedchem.5c01073

7. Drexler M, Kanavos I, Krauss D, Moreno-Alcántar G, Smith L.M, George M.E, Witney T.H, Lobinski R, Ronga L, Casini A, Design of porous self-assembled homoleptic and heteroleptic Pd²⁺ cages incorporating silicon-based fluoride acceptors: the way towards nuclear imaging applications, Inorg. Chem. Front., 2025, 12, 6309-6325. DOI:10.1039/D5QI01092F 

8. O. Moreno, Im. Azzeggarh, J. P. Holland, A. D. Windhorst, J. Llop, One-Pot Base-Free Suzuki-Miyaura [11C]Methylation: Kinetic and Mechanistic Insights. Chemistry Eur. J., 2026; 32:e03251. DOI:10.1002/chem.202503251

9. Willnhammer N, Böhm F.A, Vlaswinkel C, Rieder L, Bogenberger D, Krauss D, Zuber J, van der Wildt B, Poot A, Pöthig A, Moreno-Alcántar G, Casini A, Post-assembly modification of Pt(II) metallacages provides an open door to medicinal applications, Cell Reports Physical Science, 2026. DOI:10.1016/j.xcrp.2026.103249

10. Schuderer F, Silva R D M, Pinto, C I G.,  Koller L, Stangl S, Gano L, Cavaco M, Castanho M, Mendes F, Kossatz S, Correia J G, Casini A, Chimeric peptide-based radiopharmaceuticals for glioblastoma imaging and therapy by targeting mHsp70 and enhancing BBB penetration, Chemical Science, 2026. DOI:10.1039/D6SC00011H

11. Barber A. R, Edwards R. S, dos Santos S. N, Emanuelli A, Tyrrell W. E, Carrascal-Minino A, Sunassee K, Alam I. S, Cooke G, Witney, T. H. Imaging xCT with Immuno-PET in Therapy-Resistant Non–Small Cell Lung Cancer, J Nucl Med. 2026. DOI:10.2967/jnumed.126.27292